The prevention of diabetic microvascular complications of diabetes: Is there a role for lipid lowering?
- 30 June 2005
- journal article
- review article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 68, S3-S14
- https://doi.org/10.1016/j.diabres.2005.03.015
Abstract
No abstract availableKeywords
This publication has 92 references indexed in Scilit:
- Rosuvastatin-Induced Arrest in Progression of Renal DiseaseCardiology, 2004
- The association between statin use and age related maculopathyBritish Journal of Ophthalmology, 2003
- The Role of Lipids in the Development of Diabetic Microvascular ComplicationsAmerican Journal of Cardiovascular Drugs, 2003
- Direct in vivo evidence of a vascular statin: a single dose of cerivastatin rapidly increases vascular endothelial responsiveness in healthy normocholesterolaemic subjectsBritish Journal of Clinical Pharmacology, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Effect of lipid reduction on the progression of renal disease: A meta-analysisKidney International, 2001
- Role of hyperlipidemia in progressive renal disease: Focus on diabetic nephropathyKidney International, 1999
- Recent advances in statins and the kidneyKidney International, 1999
- Lipid profiles and blood pressure: are they risk factors for the development of early background retinopathy and incipient nephropathy in children with insulin‐dependent diabetes mellitus?Acta Paediatrica, 1996
- Apolipoprotein-B-Containing Lipoproteins and the Progression of Renal InsufficiencyNephron, 1993